Related Experiment Videos
The mutagenicity of heterocyclic N-nitrosamines for Salmonella typhimurium
Abstract:
14 carcinogenic and noncarcinogenic heterocyclic N-nitrosamines were evaluated for mutagenicity to Salmonella typhimurium TA-1535, which responds to mutagens inducing base-pair substitutions. Both suspension and plate tests were used, with mouse and rat liver in vitro metabolic activation systems. All carcinogenic nitrosamines showed a positive response in at least one test system, as did the noncarcinogens. In general, the mutagenic responses obtained with mouse liver were equal to, or greater than, the responses obtained with rat liver in both the suspension and plate tests. Although it is difficult to make quantitative comparisons between plate and suspension tests, both systems appeared to be responsive to the same dose ranges for the individual nitrosamines.
Insights
This study evaluated 14 N-nitrosamines for mutagenicity using Salmonella typhimurium TA-1535. Both carcinogenic and noncarcinogenic compounds showed mutagenic potential, with mouse liver generally yielding stronger responses than rat liver.
Area of Science:
- Toxicology
- Genetics
- Chemical carcinogenesis
Background:
- Heterocyclic N-nitrosamines are a class of compounds known for their carcinogenic potential.
- Assessing the mutagenicity of these compounds is crucial for understanding their toxicological profiles and potential health risks.
Purpose of the Study:
- To evaluate the mutagenicity of 14 carcinogenic and noncarcinogenic heterocyclic N-nitrosamines.
- To compare the mutagenic responses using different in vitro metabolic activation systems (mouse and rat liver) and test formats (suspension and plate tests).
Main Methods:
- Mutagenicity testing of N-nitrosamines using Salmonella typhimurium strain TA-1535.
- In vitro metabolic activation using mouse and rat liver preparations.
- Employing both suspension and plate assay methods.
Main Results:
- All tested carcinogenic N-nitrosamines induced mutations in Salmonella typhimurium TA-1535.
- Noncarcinogenic N-nitrosamines also exhibited mutagenic activity in the tested systems.
- Mutagenic responses were generally higher with mouse liver activation compared to rat liver activation.
- Both suspension and plate tests demonstrated responsiveness within similar dose ranges for individual nitrosamines.
Conclusions:
- Heterocyclic N-nitrosamines, regardless of carcinogenic status, can exhibit mutagenicity.
- Mouse liver metabolic activation may be more sensitive for detecting N-nitrosamine mutagenicity than rat liver.
- Both suspension and plate assays are viable methods for assessing N-nitrosamine mutagenicity.